- Pahwa R, Stacy MA, Factor SA, et al, on behalf of the EASE-PD Adjunct Study Investigators. Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease. Neurology. 2007;68:1108-1115.
- Data on file, GlaxoSmithKline.
- Tompson DJ, Vearer D. Steady-state pharmacokinetic properties of a 24-hour prolonged-release formulation of ropinirole: results of two randomized studies in patients with Parkinson's disease. Clin Ther. 2007;29:2654-2666.
- Prescribing Information for REQUIP XL.
Important Safety Information About REQUIP XL
- Prescription REQUIP XL is not for everyone.
- REQUIP XL may cause you to fall asleep or feel very sleepy during normal activities such as driving; or to faint or feel dizzy, nauseated, or sweaty when you stand up.
- Tell your doctor if you experience these or the following problems, or if you drink alcohol or are taking other medicines that make you drowsy.
- Side effects may include nausea, dizziness, drowsiness or sleepiness, headache, and sudden uncontrolled movements (dyskinesia).
- Increase or decrease in blood pressure and heart rate may occur.
- Hallucinations may occur at any time during treatment.
- Also tell your doctor if you experience new or increased gambling, sexual, or other intense urges while taking REQUIP XL.
- REQUIP XL may increase the side effects of L-dopa. Most patients were not bothered enough to stop taking REQUIP XL.